Birkenstock Holding PLC (NYSE:BIRK) Short Interest Up 16.5% in February

Birkenstock Holding PLC (NYSE:BIRK) was the target of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 10,857,673 shares, a growth of 16.5% from the February 12th total of 9,317,763 shares. Based on an average daily volume of 2,718,556 shares, the short-interest ratio is currently 4.0 days. Approximately 5.9% of the shares of the company are sold short. Approximately 5.9% of the shares of the company are sold short. Based on an average daily volume of 2,718,556 shares, the short-interest ratio is currently 4.0 days.

Birkenstock Stock Down 1.5%

BIRK opened at $36.67 on Thursday. The company has a market capitalization of $6.74 billion, a PE ratio of 16.06, a price-to-earnings-growth ratio of 1.41 and a beta of 1.06. The firm has a 50-day simple moving average of $39.46 and a two-hundred day simple moving average of $42.08. The company has a quick ratio of 1.04, a current ratio of 3.13 and a debt-to-equity ratio of 0.46. Birkenstock has a 52 week low of $35.70 and a 52 week high of $59.50.

Birkenstock (NYSE:BIRK) last issued its earnings results on Thursday, December 18th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.20. Birkenstock had a return on equity of 13.41% and a net margin of 17.68%.The firm had revenue of $617.67 million for the quarter, compared to analysts’ expectations of $521.12 million. During the same period in the previous year, the firm posted $0.29 earnings per share. The business’s revenue was up 15.5% compared to the same quarter last year. Analysts forecast that Birkenstock will post 1.77 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently weighed in on BIRK. Morgan Stanley restated a “positive” rating and set a $47.00 target price on shares of Birkenstock in a research note on Tuesday, January 27th. Telsey Advisory Group reiterated an “outperform” rating and issued a $60.00 price target on shares of Birkenstock in a research note on Thursday, February 12th. Weiss Ratings reissued a “hold (c-)” rating on shares of Birkenstock in a report on Monday, December 29th. UBS Group restated a “buy” rating on shares of Birkenstock in a research report on Monday, February 9th. Finally, Sanford C. Bernstein dropped their price objective on Birkenstock from $55.00 to $50.00 and set a “market perform” rating for the company in a research note on Thursday, January 15th. Sixteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $60.12.

Institutional Trading of Birkenstock

A number of large investors have recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. lifted its position in Birkenstock by 11.9% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 11,886,454 shares of the company’s stock valued at $486,156,000 after purchasing an additional 1,264,841 shares during the last quarter. Bamco Inc. NY grew its stake in shares of Birkenstock by 25.4% in the 4th quarter. Bamco Inc. NY now owns 7,966,037 shares of the company’s stock worth $325,811,000 after buying an additional 1,612,236 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Birkenstock by 61.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,093,620 shares of the company’s stock worth $126,534,000 after buying an additional 1,181,919 shares during the last quarter. Balyasny Asset Management L.P. raised its position in shares of Birkenstock by 214.3% during the 2nd quarter. Balyasny Asset Management L.P. now owns 2,991,187 shares of the company’s stock valued at $147,107,000 after buying an additional 2,039,623 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD raised its position in shares of Birkenstock by 0.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,950,380 shares of the company’s stock valued at $120,672,000 after buying an additional 25,585 shares in the last quarter. Institutional investors own 19.93% of the company’s stock.

Birkenstock Company Profile

Birkenstock Group AG, listed on the New York Stock Exchange under the symbol BIRK, is a global footwear manufacturer renowned for its anatomically contoured footbeds and iconic sandal designs. The company’s core product lines include classic models such as the Arizona, Boston and Madrid, alongside a range of clogs, shoes and orthotic insoles. In addition to footwear, Birkenstock offers complementary accessories, including socks and leather care products, reinforcing its commitment to foot health and comfort.

Birkenstock reaches consumers through a diversified distribution network that combines direct-to-consumer channels—such as branded retail stores and e-commerce platforms—with wholesale partnerships spanning specialty footwear retailers, department stores and select online marketplaces.